Evidence map›Paper›PMID 34832868›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Design and Microwave Synthesis of New (5

Khadidja Bourahla, Solène Guihéneuf, Emmanuelle Limanton, Ludovic Paquin, Rémy Le Guével, Thierry Charlier, Mustapha Rahmouni, Emilie Durieu, Olivier Lozach, François Carreaux and 2 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Cancers · 2024
    Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Khadidja BourahlaInstitut des Sciences Chimiques de Rennes ISCR UMR CNRS 6226, Université de Rennes 1, Bât. 10A, Campus de Beaulieu, CS 74205, 263 Avenue du Général Leclerc, CEDEX, 35042 Rennes, France.ORCID 0000-0003-0788-0381
Solène GuihéneufInstitut des Sciences Chimiques de Rennes ISCR UMR CNRS 6226, Université de Rennes 1, Bât. 10A, Campus de Beaulieu, CS 74205, 263 Avenue du Général Leclerc, CEDEX, 35042 Rennes, France.
Emmanuelle LimantonInstitut des Sciences Chimiques de Rennes ISCR UMR CNRS 6226, Université de Rennes 1, Bât. 10A, Campus de Beaulieu, CS 74205, 263 Avenue du Général Leclerc, CEDEX, 35042 Rennes, France.ORCID 0000-0003-2828-9937
Ludovic PaquinInstitut des Sciences Chimiques de Rennes ISCR UMR CNRS 6226, Université de Rennes 1, Bât. 10A, Campus de Beaulieu, CS 74205, 263 Avenue du Général Leclerc, CEDEX, 35042 Rennes, France.
Rémy Le GuévelImPACcell Platform, SFR Biosit, Université de Rennes 1, Bât. 8, Campus Villejean, 2 Avenue du Prof. Léon Bernard, CS 34317, CEDEX, 35043 Rennes, France.
Thierry CharlierImPACcell Platform, SFR Biosit, Université de Rennes 1, Bât. 8, Campus Villejean, 2 Avenue du Prof. Léon Bernard, CS 34317, CEDEX, 35043 Rennes, France.
Mustapha RahmouniLaboratoire de Synthèse et de Catalyse, Université Ibn Khaldoun, Tiaret 14000, Algeria.
Emilie DurieuPerha Pharmaceuticals & ManRos Therapeutics, "From Sea to Pharmacy", Hôtel de Recherche, 29680 Roscoff, France.
Olivier LozachProtein Phosphorylation & Human Disease Group, Station Biologique, 29680 Roscoff, France.ORCID 0000-0003-0568-4387
François CarreauxInstitut des Sciences Chimiques de Rennes ISCR UMR CNRS 6226, Université de Rennes 1, Bât. 10A, Campus de Beaulieu, CS 74205, 263 Avenue du Général Leclerc, CEDEX, 35042 Rennes, France.
Laurent MeijerPerha Pharmaceuticals & ManRos Therapeutics, "From Sea to Pharmacy", Hôtel de Recherche, 29680 Roscoff, France.
Jean-Pierre BazureauInstitut des Sciences Chimiques de Rennes ISCR UMR CNRS 6226, Université de Rennes 1, Bât. 10A, Campus de Beaulieu, CS 74205, 263 Avenue du Général Leclerc, CEDEX, 35042 Rennes, France.
Centre National de la Recherche Scientifique · FRStation Biologique de Roscoff · FRInserm · FRManRos Therapeutics (France) · FRStructure Fédérative de Recherche en Biologie et Santé de Rennes · FRUniversité IBN Khaldoun Tiaret · DZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we report on the synthesis of libraries of new 5-arylidene-2-thioxo-1,3-thiazolidin-4-ones 3 (twenty-two compounds) and new 2-amino-5-arylidene-1,3-thiazol-4(5

Indexed as

1,3-thiazolidin-4-onecell linesDYRK1AinhibitionKnoevenagel condensationmicrowaveprotein kinasesulphur/nitrogen displacement

Identifiers

PMID34832868
PMCPMC8623179
OpenAlexW3210278381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.